A healthcare-branded AI could make an output feel more trustworthy, but that does not establish that doctors check it less carefully. The useful question is testable: when the underlying output is identical, does describing an agent as clinical change error recognition, confidence or willingness to challenge it? No Heidi II versus Muse result is being claimed here.
This article examines evidence and product documentation available on 29 September 2026. It is published by iatroX and includes iatroX's own learning tools in the discussion, so the same distinction between reassuring design and demonstrated performance applies to our products.
Clinical familiarity can be useful without settling reliability
A familiar workflow, appropriate terminology and an understandable presentation can reduce the effort required to use software. They can also make a proposed action appear to fit ordinary practice before its underlying assumptions have been examined. Whether that familiarity improves judgement or merely increases acceptance is an empirical question.
The distinction is between justified trust and reassurance. Justified trust has a specific basis: performance in comparable tasks, clear limitations, inspectable information and experience of how the system handles exceptions. Reassurance can come from a polished interface, a professional-looking document or a description that sounds close to the user's own role.
These categories need not be opposites. A well-designed specialist system could be both familiar and demonstrably useful. The error would be to use the first quality as evidence for the second, or to assume that a general-purpose brand necessarily produces more careful scrutiny.
Heidi's 28 September 2026 launch statement explicitly retains clinical judgement with clinicians. The research question is how independently that judgement operates during use, not whether the statement appears in the documentation.
What clinical research actually shows
A randomised clinical-vignette study published in JAMA on 19 December 2023 included 457 clinicians who were randomised and completed at least one vignette. They assessed causes of acute respiratory failure. Standard AI predictions improved diagnostic accuracy, but systematically biased predictions reduced it by 11.3 percentage points relative to baseline. Adding image-based explanations did not significantly mitigate the adverse effect of biased predictions.
This was not a study of Heidi II, Muse, clinical branding or an agent completing practice tasks. It does show why a professional reviewer and an explanation should not automatically be treated as sufficient safeguards. Its findings support investigating effective error detection; they do not establish that one current product makes clinicians less sceptical than another.
The positive findings matter too. The appropriate aim is not to make users distrust all AI suggestions. It is to improve discrimination between support that helps and support that should be questioned. Rejecting correct assistance indiscriminately can be a poor outcome, just as accepting incorrect assistance can be.
A coherent package can conceal the original omission
Imagine a fictional follow-up review in which an old working explanation appears prominently in the prepared summary. A more recent patient message describes a changed chronology, but that message is omitted. The proposed next step then follows logically from the old explanation, and a relevant research citation makes the package appear well supported.
The summary, recommendation and citation may agree with one another because they all depend on the same incomplete account. Their consistency is not independent corroboration. The key question is whether the clinician notices the missing recent information before approving the proposed direction.
A review focused on the final wording might miss this. A review that asks which facts would change the plan has a better chance of exposing the omission, but that advantage should itself be tested rather than declared. Requiring users to repeat every automated step would defeat the purpose of assistance and may create a different form of burden.
This scenario is a proposed failure mechanism, not an allegation about either product. It also applies to human-prepared summaries and iatroX outputs: fluent organisation can be useful while still requiring scrutiny of consequential assumptions.
A blinded educational experiment could separate the effects
One study could use simulated case outputs developed independently of either vendor. Participants would see the same underlying material, but receive different descriptions: a general-purpose assistant, a clinician-focused assistant or an unnamed support system. The study should make clear through its approved research arrangements that the outputs are experimental materials, not authenticated vendor responses.
Randomisation should prevent the product description from being confounded with output quality. Case order should be balanced, and participants should not encounter the same case repeatedly under different labels in a way that makes the answer obvious. Raters assessing responses should be unaware of the description assigned to each participant.
The case set should contain correct outputs as well as plausible mistakes. Examples could include a missing contradiction, an outdated instruction, a real citation that does not support the proposed conclusion and a case in which the system appropriately requests more information. Independent clinical reviewers should define consequential errors and acceptable responses before participants start.
The primary outcome could be recognition and appropriate handling of those errors. Secondary outcomes could examine confidence, unnecessary rejection of correct assistance, time spent reviewing and whether the participant identifies the source of the problem. Sample size should follow a prespecified analysis and power calculation, not an invented expectation of the effect.
This is a proposed protocol, not a completed experiment. Results would be published from an actual run, with methods and limitations, rather than inferred from the plausibility of the hypothesis.
Measure confidence in the right thing
A single question asking whether someone "trusts the AI" is too broad for this purpose. A clinician could trust the software to retrieve a document while remaining uncertain about its interpretation. They could also feel confident that they have checked a suggestion without having noticed the missing fact that matters.
An evaluation should therefore separate confidence in the agent, confidence in the final decision and confidence in the clinician's own ability to detect an error. These beliefs may move in different directions after assistance.
Calibration matters more than maximising or minimising confidence. Higher confidence is appropriate when it follows better understanding and a correct decision. The concerning result would be increased confidence without improved performance, especially when incorrect suggestions are accepted more readily.
A delayed assessment could examine whether the learner can transfer the relevant distinction to a new case. That would address learning separately from immediate task completion. It would not, by itself, establish long-term deskilling or predict real-world patient outcomes.
Personalisation adds another variable
Meta's September 2026 design account describes persistent memory, editable memory files, custom avatars and adjustable proactivity. These are features of the user-agent relationship, not evidence of improved clinical judgement.
A separate experiment could ask whether remembered preferences influence how users receive an output. Remembering a preference for concise letters is different from repeatedly reinforcing a familiar clinical interpretation. The former concerns presentation; the latter could affect what is investigated or questioned.
A useful test would introduce new information that conflicts with an established preference or routine. Does the interface make the conflict visible? Does the user recognise it? A calm, familiar response should not receive a favourable safety score merely because it feels comfortable.
For Heidi II, comparable questions should be tied to the documented scope of its particular memory functionality. The word "Memory" should not be expanded into an assumption of unrestricted patient knowledge or a proven mechanism of cognitive influence.
Preserve learning without inventing a protective effect
As described by iatroX in September 2026, the Socratic Tutor opens around an attempted question and uses targeted follow-ups to explore the learner's misconception. That design creates an opportunity to make reasoning visible rather than only reading a finished explanation.
An educator could pair an independent attempt with feedback, then ask the learner to apply the distinction to a different simulated case. The value being sought is active processing and better recognition of relevant information. It should be measured through what the learner can subsequently do, not inferred from the presence of a tutoring interface.
iatroX's September 2026 CPD tools also require the learner to review and personalise the draft record. A professional learning record is not automatically accredited CME, and neither a Tutor session nor a simulation certifies competence to supervise Heidi II or Muse. No claim is made that an iatroX subscription prevents deskilling.
Verdict by reader scenario
For educators, the strongest next step is to test presentation effects separately from output quality. For buyers, familiar clinical language is a usability consideration, not a substitute for deployment-specific evidence. For clinicians, the practical aim is selective challenge: retain enough independent understanding to recognise a consequential inconsistency without duplicating every routine task.
For anyone comparing Heidi II and Muse, the defensible conclusion is not that a clinical brand creates dangerous trust. It is that the proposed advantage of specialisation should include demonstrably better human-system judgement, rather than being assumed from the name on the interface.
Frequently asked questions
Is there evidence that Heidi II users are more vulnerable to automation bias than Muse users?
No such comparison is established by the sources reviewed on 29 September 2026. The branding effect discussed here is a hypothesis for testing.
Did the JAMA study test current clinical AI agents?
No: the December 2023 study examined AI predictions and image-based explanations in clinical vignettes. It informs questions about oversight but does not measure either product's agent workflows.
Can Socratic tutoring guarantee protection against deskilling?
No: asking learners to explain and revisit their reasoning is an educational design choice, not proof of protection against long-term skill loss. Retained competence needs its own assessment.
Practise explaining and challenging clinical reasoning with Tutor →